查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048338

顎骨增容市場－全球產業規模、佔有率、趨勢、機會、預測：依手術方式、最終用途、地區和競爭格局分類，2021-2031年

Chin Augmentation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure (Surgical, Non-Surgical), By End-use (Cosmetic Surgery Center, Hospitals, MedSpas), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球顎骨增容市場預計將從 2025 年的 17.1 億美元大幅成長至 2031 年的 25.2 億美元，複合年成長率為 6.68%。

臨床上稱為「頦成形術」的這項手術，透過植入植入或進行骨骼重塑，重塑或增加下顎骨的體積，從而改善臉部整體的平衡感。其成長主要受消費者對臉部對稱性日益成長的關注、人們對整形手術接受度的提高以及需求的增加所驅動，尤其是在希望突出下顎線條的男性群體中。根據美國整形外科醫師協會的數據，2024年其會員醫師共進行了5529例下顎骨增大手術，顯示對這種臉部整形手術的需求穩定。然而，儘管需求穩定，但由於手術費用高昂和手術併發症風險等因素，該市場仍面臨許多障礙。這些因素可能會阻礙對價格敏感和規避風險的患者接受治療。

市場概覽
預測期 2027-2031
市場規模：2025年 17.1億美元
市場規模：2031年 25.2億美元
複合年成長率：2026-2031年 6.68%
成長最快的細分市場 外科
最大的市場 北美洲

市場促進因素

推動市場成長的主要動力是對微創和非手術皮膚填充劑日益成長的需求。與手術下顎整形相比，這些方法恢復時間更短，風險更低，因此越來越受到患者的青睞。透明質酸和羥基磷灰石鈣填充劑的普及尤其體現了這一轉變，它們為下顎前突和輪廓塑形提供了可逆且靈活的選擇，顯著拓展了市場，使其不再局限於傳統手術的患者群體。這一趨勢也反映在全球手術數量的成長；根據國際美容整形外科學會（ISAPS）預測，到2025年6月，全球透明質酸注射手術量預計將成長5.2%，達到約630萬例。這顯示注射填充劑正逐漸成為臉部輪廓塑形的主流。同時，男性下顎輪廓整形手術的日益流行，也推動了市場成長。這種流行源自於美學觀念的轉變，即認為輪廓分明、線條硬朗的下顎線與健身的體魄和乾練的形象聯繫在一起。男性正逐漸成為重要的消費群體，隨著人們對整容手術的偏見逐漸減少，他們開始積極尋求各種治療方案，以改善面部結構平衡，並矯正正面部輪廓的不足。美國臉部整形與重組外科學會 (AAFPRS) 的產業數據也印證了這個人口結構的變化。 AAFPRS 在 2025 年 2 月發布的《2024 年度趨勢調查》中指出，92% 的受訪外科醫生曾為男性患者提供過治療，這反映出患者群體正在不斷擴大。此外，高德美 (Galderma) 發布的 2025 年報告顯示，2024 年全年注射類美容產品的淨銷售額達到 22.99 億美元，充分展現了這些手術的經濟規模。

市場挑戰

下顎整形手術的高昂費用是阻礙市場進一步擴張的主要經濟障礙。由於下顎整形通常被歸類為選擇性美容手術，一般不在醫療保險的承保範圍內，這意味著患者必須自行承擔全部費用。這種定價結構實際上將目標市場限制在高所得人群，有效地將大量重視臉部對稱性但缺乏可支配收入來承擔這項非必要支出的男性和女性排除在外。因此，高昂的費用往往會嚇退那些原本會被美容效果吸引的潛在客戶。近期產業數據也印證了這項經濟挑戰，凸顯了高昂的初始成本。根據美國整形外科醫師協會的報告，2024年下顎整形手術的平均醫師收費為3,641美元。值得注意的是，該數字僅包含醫生費用，不包括其他必要費用，例如手術室費用、麻醉費用和檢查費用，這意味著最終費用可能會高得多。這些累積的經濟負擔直接阻礙了全球手術數量的成長，並阻止了市場在價格敏感型消費者中充分發揮其潛力。

市場趨勢

客製化3D列印顎骨植入的出現正在革新市場，突破了傳統植入形狀的限制。外科醫生擴大使用電腦輔助設計（CAD）來製作與患者骨骼解剖結構精準匹配的植入（PSI）。這確保了卓越的輪廓貼合度，並將植入移位的風險降至最低。這項技術進步使得精準矯正不對稱和小顎畸形成為可能，而無需像傳統多孔聚乙烯或矽膠塊那樣進行大規模的術中塑形工作。這種個人化方案的商業性可行性已在領先技術供應商的收入成長中得到充分體現。 MaterialRise在其2025年2月發布的2024年第四季及全年財報中指出，其醫療收入在2024年全年成長了14.8%，凸顯了市場對個人化手術解決方案和3D列印醫療設備的強勁需求。同時，自體脂肪移植的應用也顯著增加，隨著患者尋求天然、生物相容性強的替代合成材料，治療趨勢正在改變。這項技術是指從患者自身提取脂肪組織來改善下顎線和下巴，其雙重優勢在於既能最佳化取脂部位的輪廓，又能避免異體植入植入可能引起的排異反應。 GLP-1類減重藥物的廣泛使用進一步強化了這一趨勢，因為這類藥物通常會導致臉部容量流失，促使人們尋求利用自身生物組織進行修復以恢復臉部輪廓的方法。美國臉部整形與重組外科學會（AAFPRS）的最新臨床數據也支持了這種消費者偏好的轉變。根據AAFPRS於2025年2月發布的《2024年度趨勢調查》，臉部整形外科醫師進行的脂肪移植手術平均數量較去年同期增加了50%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球顎骨增容市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依治療方法（手術、非手術）
    • 依用途分類（整形外科中心、醫院、醫療水療中心）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美顎骨增容市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲顎骨增容市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區顎骨增容市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲顎骨增容市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美顎骨增容市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球顎骨增容市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • New York Plastic Surgical Group
  • Westlake Dermatology & Cosmetic Surgery
  • Nazarian Plastic Surgery Inc.
  • Ruby Surgery & Aesthetics
  • Cadogan Clinics Limited
  • UK Aesthetic Limited
  • UK Healthcare Aesthetics Center
  • Marroquin & Sandoval Plastic Surgery
  • Advanced Cosmetic Surgery Limited
  • Orange County Facial Plastic Surgery

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20731

The global chin augmentation market is projected to expand significantly, rising from USD 1.71 billion in 2025 to USD 2.52 billion by 2031, at a compound annual growth rate (CAGR) of 6.68%. This surgical procedure, known clinically as mentoplasty, involves reshaping or enhancing the chin through implants or bone advancement to improve overall facial balance. Its growth is primarily fueled by consumers' increasing focus on facial symmetry and the growing acceptance of aesthetic interventions, particularly among men seeking to define their jawlines.According to data from the American Society of Plastic Surgeons, 5,529 chin augmentation procedures were performed by its member surgeons in 2024, indicating consistent demand for this specific facial contouring surgery. However, despite this steady interest, the market faces notable hurdles due to the high cost of the procedure and potential risks of surgical complications, factors that can deter both price-sensitive and risk-averse patients from pursuing treatment.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.71 Billion
Market Size 2031USD 2.52 Billion
CAGR 2026-20316.68%
Fastest Growing SegmentSurgical
Largest MarketNorth America

Market Driver

A primary catalyst propelling the market is the escalating demand for minimally invasive and non-surgical dermal fillers. Patients are increasingly opting for these procedures due to reduced downtime and lower risks compared to surgical mentoplasty. This shift is marked by the prevalent use of hyaluronic acid and calcium hydroxylapatite fillers, which provide a reversible and adaptable option for chin projection and contouring, thereby significantly expanding the market beyond traditional surgical candidates. This trend is evidenced by global procedure volumes, with the International Society of Aesthetic Plastic Surgery (ISAPS) reporting a 5.2% increase in hyaluronic acid procedures worldwide, totaling approximately 6.3 million treatments by June 2025, highlighting the dominance of injectable solutions in facial profiling.Simultaneously, the market is being driven by the rising adoption of jawline contouring among men, spurred by evolving aesthetic ideals that associate a defined, strong jawline with fitness and executive presence. Men are becoming a crucial consumer segment, actively seeking enhancements to improve facial structural balance and correct weak profiles, with less stigma now attached to cosmetic interventions. This demographic shift is underscored by industry data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), which indicated in its February 2025 '2024 Annual Trends Survey' that 92% of surveyed surgeons treated male patients, reflecting a broadening patient base. Furthermore, Galderma's 2025 report showing full-year 2024 Injectable Aesthetics net sales of USD 2,299 million demonstrates the financial scale supporting these procedures.

Market Challenge

The significant cost of chin augmentation presents a substantial economic barrier, hindering broader market expansion. As mentoplasty is typically categorized as an elective cosmetic procedure, it is generally not covered by medical insurance, requiring patients to bear the full financial burden themselves. This pricing structure inherently limits the accessible market primarily to high-income individuals, effectively excluding a considerable portion of the population, both male and female, who prioritize facial symmetry but lack the disposable income for such discretionary expenses. Consequently, these substantial costs frequently deter potential clients who might otherwise be motivated by the aesthetic benefits.Recent industry data corroborates this financial challenge by highlighting the steep baseline expenses involved. The American Society of Plastic Surgeons reported that in 2024, the average surgeon fee for chin augmentation was $3,641. It is critical to note that this figure solely covers the physician's charge and does not include additional essential costs such as facility fees, anesthesia, and medical tests, which can considerably elevate the final price. This cumulative financial weight directly impedes the global growth of procedure volumes, preventing the market from realizing its full potential among price-sensitive consumers.

Market Trends

The emergence of custom 3D-printed chin implants is significantly innovating the market by overcoming the limitations of conventional prosthetic shapes. Surgeons are increasingly employing computer-aided design (CAD) to create patient-specific implants (PSIs) that precisely match the individual's bony anatomy, ensuring superior contour adaptation and minimizing the risk of implant migration. This technological advancement enables accurate correction of asymmetry and microgenia without the extensive intraoperative shaping typically required for traditional porous polyethylene or silicone blocks. The commercial viability of this personalized approach is evident in the financial growth of key technology providers; Materialise reported a 14.8% increase in revenue from its Medical segment for the full year 2024, as per its February 2025 'Fourth Quarter and Full Year 2024 Results', highlighting the surging demand for personalized surgical solutions and 3D-printed medical devices.Concurrently, there is a notable shift towards autologous fat grafting, reshaping procedural preferences as patients seek natural, biocompatible alternatives to synthetic materials. This technique involves harvesting adipose tissue from the patient's own body to augment the chin and jawline, offering the dual advantages of donor site contouring and eliminating the risks of foreign body rejection associated with alloplastic implants. This trend is further amplified by the widespread use of GLP-1 weight-loss medications, which often lead to facial volume loss, prompting individuals to seek restorative options that utilize their own biology to regain structural definition. Recent clinical data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) substantiates this changing consumer preference, with their February 2025 '2024 Annual Trends Survey' reporting a 50% rise in the average number of fat grafting procedures performed by facial plastic surgeons over the preceding year.

Key Market Players

  • New York Plastic Surgical Group
  • Westlake Dermatology & Cosmetic Surgery
  • Nazarian Plastic Surgery Inc.
  • Ruby Surgery & Aesthetics
  • Cadogan Clinics Limited
  • UK Aesthetic Limited
  • UK Healthcare Aesthetics Center
  • Marroquin & Sandoval Plastic Surgery
  • Advanced Cosmetic Surgery Limited
  • Orange County Facial Plastic Surgery

Report Scope

In this report, the Global Chin Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chin Augmentation Market, By Procedure

  • Surgical
  • Non-Surgical

Chin Augmentation Market, By End-use

  • Cosmetic Surgery Center
  • Hospitals
  • MedSpas

Chin Augmentation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chin Augmentation Market.

Available Customizations:

Global Chin Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chin Augmentation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Procedure (Surgical, Non-Surgical)
    • 5.2.2. By End-use (Cosmetic Surgery Center, Hospitals, MedSpas)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Chin Augmentation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Procedure
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chin Augmentation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Procedure
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Chin Augmentation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Procedure
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Chin Augmentation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Procedure
        • 6.3.3.2.2. By End-use

7. Europe Chin Augmentation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Procedure
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chin Augmentation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Procedure
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Chin Augmentation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Procedure
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Chin Augmentation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Procedure
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Chin Augmentation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Procedure
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Chin Augmentation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Procedure
        • 7.3.5.2.2. By End-use

8. Asia Pacific Chin Augmentation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Procedure
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chin Augmentation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Procedure
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Chin Augmentation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Procedure
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Chin Augmentation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Procedure
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Chin Augmentation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Procedure
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Chin Augmentation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Procedure
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Chin Augmentation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Procedure
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chin Augmentation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Procedure
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Chin Augmentation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Procedure
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Chin Augmentation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Procedure
        • 9.3.3.2.2. By End-use

10. South America Chin Augmentation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Procedure
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chin Augmentation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Procedure
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Chin Augmentation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Procedure
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Chin Augmentation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Procedure
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chin Augmentation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. New York Plastic Surgical Group
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Westlake Dermatology & Cosmetic Surgery
  • 15.3. Nazarian Plastic Surgery Inc.
  • 15.4. Ruby Surgery & Aesthetics
  • 15.5. Cadogan Clinics Limited
  • 15.6. UK Aesthetic Limited
  • 15.7. UK Healthcare Aesthetics Center
  • 15.8. Marroquin & Sandoval Plastic Surgery
  • 15.9. Advanced Cosmetic Surgery Limited
  • 15.10. Orange County Facial Plastic Surgery

16. Strategic Recommendations

17. About Us & Disclaimer